Motilal Oswal: Robust India Sales, Better Operating Leverage Drive Cipla’s Q1 Earnings 
Vaccine vials enter the conveyor of a machine during inspection and screening for defects at the Serum Institute of India Ltd. pharmaceutical plant in Pune, Maharashtra(Photographer Sanjit Das/Bloomberg)

Motilal Oswal: Robust India Sales, Better Operating Leverage Drive Cipla’s Q1 Earnings 

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportun...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.